MIGHTY THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 23 Jan 2026)
What this means for you
Not registered yet, but its 10 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98544515
- Mark type
- Stylized text
- Filed
- 10 May 2024
- Published for opposition
- 24 Dec 2024
- Attorney of record
- Tricia L. Schulz
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
- Class 042 — Scientific and technological services: Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system field
Owner
- Stealth BioTherapeutics Inc., Needham, MA, US
- Stealth BioTherapeutics Inc., Needham, MA, US
Prosecution history
- 06 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2026 — SOU EXTENSION 2 GRANTED
- 23 Jan 2026 — SOU EXTENSION 2 FILED
- 23 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2025 — SOU EXTENSION 1 GRANTED
- 18 Jul 2025 — SOU EXTENSION 1 FILED
- 18 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2024 — PUBLISHED FOR OPPOSITION
- 18 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED